Zemuron and Atenolol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zemuron (rocuronium bromide) and Atenolol (atenolol). Common drug interactions include cholelithiasis among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Zemuron and Atenolol. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Zemuron?

Zemuron has active ingredients of rocuronium bromide. eHealthMe is studying from 873 Zemuron users. Check the latest studies of Zemuron.

What is Atenolol?

Atenolol has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 176,618 Atenolol users. Check the latest studies of Atenolol.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 26, 2026

21 people who take Zemuron and Atenolol together, and have interactions are studied.

Zemuron and Atenolol drug interactions.

What are the common drug interactions of Zemuron and Atenolol, by gender? *:

female:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Depression
  4. Fungal infection
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Peripheral vascular disorder
  7. Renal injury (kidney injury)
  8. Sinusitis (inflammation of sinus)
  9. Abdominal pain
  10. Acute respiratory distress syndrome

male:

  1. Pain
  2. Abdominal pain
  3. Dyslipidaemia (abnormal amount of lipids)
  4. Eructation (release of gas from the digestive tract)
  5. Hunger
  6. Mitral valve incompetence (inefficient heart valve)
  7. Nausea (feeling of having an urge to vomit)
  8. Oral herpes (viral infection of mouth)
  9. Sinus bradycardia (an unusually slow heartbeat due to heart disease)
  10. Ventricular hypertrophy (enlargement of ventricles (lower chambers) in the heart)

What are the common drug interactions of Zemuron and Atenolol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood pressure decreased
  2. Cardiac disorder
  3. Chest discomfort
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Haemorrhage subcutaneous (bleeding from skin)
  7. Lip swelling
  8. Oedema mouth (swelling of mouth)
  9. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  10. Rash

50-59:

  1. Sinusitis (inflammation of sinus)
  2. Abdominal pain
  3. Anaemia (lack of blood)
  4. Angina pectoris (chest pain due to ischemia of the heart muscle)
  5. Angiopathy (generic term for a disease of the blood vessels)
  6. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  7. Aortic valve incompetence
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Arthropathy
  10. Asthenia (weakness)

60+:

  1. Pain
  2. Anaemia (lack of blood)
  3. Hunger
  4. Mitral valve incompetence (inefficient heart valve)
  5. Nausea (feeling of having an urge to vomit)
  6. Oral herpes (viral infection of mouth)
  7. Sinus bradycardia (an unusually slow heartbeat due to heart disease)
  8. Ventricular hypertrophy (enlargement of ventricles (lower chambers) in the heart)
  9. Abdominal pain
  10. Asthenia (weakness)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 14.29%
  2. Chest Pain: 3 people, 14.29%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Zemuron and Atenolol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zemuron and Atenolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zemuron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Atenolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zemuron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atenolol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rocuronium bromide and atenolol (the active ingredients of Zemuron and Atenolol, respectively), and Zemuron and Atenolol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: